+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Large Volume Parenteral Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6124812
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Large Volume Parenteral Market is projected to reach USD 3.99 Billion in 2026. It is expected to continue growing at a CAGR of 7.74%, reaching USD 6.30 Billion by 2032.

Large-Volume Parenteral Solutions: Executive Overview

Large-volume parenteral solutions are sterile intravenous preparations typically administered in containers holding at least 100 milliliters. They support fluid replacement, electrolyte management, nutrition, medication dilution, and perioperative care across hospitals and other clinical settings. Demand is shaped by inpatient activity, emergency care requirements, chronic disease management, surgical volume, infection-control standards, and the reliability of pharmaceutical manufacturing and distribution systems.

Healthcare Delivery Is Reshaping Parenteral Supply

The landscape is shifting toward safer, more standardized, and more resilient sterile-infusion systems. Hospitals are prioritizing ready-to-use presentations, container integrity, compatibility assurance, efficient storage, and reduced manipulation at the point of care. Supply-chain disruptions have also increased attention to dual sourcing, regional production capabilities, critical-input inventories, and quality oversight across raw materials, filling operations, packaging, and cold-chain or controlled-storage processes where applicable.

Artificial Intelligence Strengthens Quality, Planning, and Clinical Operations

Artificial intelligence can influence large-volume parenteral operations through demand sensing, production scheduling, anomaly detection, visual inspection, predictive maintenance, and inventory optimization. In hospitals, decision-support tools may help identify usage patterns, reduce waste, and improve replenishment coordination. These applications require validated data, human oversight, cybersecurity controls, explainable workflows, and compliance with applicable pharmaceutical and medical-device requirements; AI should complement, rather than replace, quality professionals and clinical judgment.

Regional Insights: Uneven Access Meets Common Quality Priorities

North America emphasizes regulatory compliance, hospital efficiency, supply continuity, and advanced automation. Europe combines strong quality expectations with procurement coordination, sustainability priorities, and pressure to improve medicine resilience. Asia-Pacific spans highly developed healthcare systems and rapidly expanding hospital capacity, creating varied requirements for affordability, local manufacturing, and distribution reach. Latin America is shaped by public procurement, import dependence in some markets, infrastructure variation, and the need for dependable access across urban and remote facilities. The Middle East is investing in healthcare capacity, specialized services, and supply-chain localization, while the African market reflects substantial variation in infrastructure, financing, sterile-production capability, and access to essential hospital therapies.

Group Insights: Regulation, Trade, and Resilience Define Priorities

ASEAN countries share priorities around affordable access, harmonized quality practices, and dependable cross-border supply while retaining different regulatory and infrastructure conditions. BRICS members represent diverse production capabilities, healthcare systems, and procurement models, with resilience and domestic capacity important across the group. The European Union benefits from regulatory coordination and regional procurement mechanisms, although member-state purchasing and reimbursement practices remain influential. G7 markets generally emphasize stringent quality systems, patient safety, automation, and continuity planning. GCC countries are strengthening healthcare infrastructure and local supply capabilities. NATO members, viewed collectively, face the additional need to maintain resilient medical supply chains during geopolitical disruption while meeting national regulatory requirements.

Country Insights: Diverse Systems Require Tailored Execution

Australia combines centralized procurement influences with geographic distribution challenges. Brazil has a broad public and private healthcare structure and must manage regional disparities and procurement complexity. Canada emphasizes universal access, hospital logistics, and continuity across a large geography. China is strengthening domestic pharmaceutical capabilities while serving varied hospital tiers. France, Germany, Italy, and Spain operate within the European regulatory environment but differ in procurement, reimbursement, and hospital organization. India combines expanding healthcare capacity with strong affordability and local-manufacturing priorities. Japan emphasizes stringent quality, reliability, and an aging-care environment. Mexico balances public-sector demand, private healthcare activity, and supply-chain variation. Russia’s operating environment is affected by domestic production priorities and trade constraints. South Korea combines advanced hospitals, technology adoption, and rigorous quality expectations. The United Kingdom focuses on national health-system procurement, resilience, and efficient hospital use. The United States places strong emphasis on sterile-manufacturing compliance, hospital supply continuity, product quality, and operational efficiency.

Actions for Leaders: Build Resilience Without Compromising Quality

Industry leaders should segment products by clinical criticality, establish qualified alternative suppliers for essential inputs, and maintain documented continuity plans for manufacturing, packaging, transport, and distribution. They should invest in contamination control, container-closure integrity, process validation, and end-to-end traceability while reducing avoidable handling at the bedside. Digital initiatives should begin with high-value use cases such as demand planning, inspection support, and maintenance, supported by validated datasets and clear accountability. Regional strategies should reflect procurement rules, reimbursement conditions, infrastructure, and local quality requirements rather than relying on a single global operating model.

Research Methodology: Evidence-Based Market Interpretation

This executive summary uses the supplied market definition for large-volume parenteral solutions and synthesizes validated industry considerations across clinical use, sterile manufacturing, regulation, procurement, logistics, technology, and healthcare delivery. The analysis compares the required regions, economic and political groups, and countries through qualitative evidence-based lenses, including healthcare infrastructure, regulatory maturity, supply-chain conditions, manufacturing capability, and access priorities. It intentionally excludes market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims.

Conclusion: Reliability, Safety, and Adaptability Will Differentiate Performance

Large-volume parenteral solutions remain closely tied to the safe functioning of hospitals and other acute-care environments. The strongest operating models will combine rigorous sterile-quality systems with resilient sourcing, efficient distribution, appropriate product formats, and disciplined use of digital technologies. Success across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific will depend on adapting execution to local healthcare structures while maintaining consistent standards for patient safety, product integrity, and supply continuity.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Large Volume Parenteral Market, by Product Type
7.1. Introduction
7.2. Colloids
7.2.1. Albumin
7.2.2. Dextrans
7.2.3. Gelatins
7.2.4. Hydroxyethyl Starch
7.3. Crystalloids
7.3.1. Balanced Electrolyte Solutions
7.3.2. Dextrose
7.3.3. Normal Saline
7.3.4. Ringer's Lactate
8. Large Volume Parenteral Market, by Packaging
8.1. Introduction
8.2. Bags
8.3. Bottles
8.3.1. Plastic
8.3.2. Glass
9. Large Volume Parenteral Market, by End User
9.1. Introduction
9.2. Ambulatory Care
9.3. Clinics
9.4. Home Care
9.5. Hospitals
10. Large Volume Parenteral Market, by Application
10.1. Introduction
10.2. Blood Volume Expansion
10.3. Fluid Replacement
10.4. Medication Delivery
10.5. Nutritional Support
11. Large Volume Parenteral Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Large Volume Parenteral Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Large Volume Parenteral Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Large Volume Parenteral Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories Inc.
16.2. Albert David Ltd.
16.3. Amanta Healthcare
16.4. B. Braun Melsungen AG
16.5. BAG Healthcare GmbH
16.6. Baxter International Inc.
16.7. Becton Dickinson & Co. (BD)
16.8. Beximco Pharmaceutical Ltd.
16.9. Cipla Limited
16.10. Cook Pharmica LLC
16.11. Fresenius Kabi AG
16.12. Grifols S.A.
16.13. ICU Medical Inc.
16.14. JW Life Science
16.15. Otsuka Pharmaceutical Co. (Otsuka Holdings Co., Ltd.)
16.16. Pfizer Inc. (including Hospira assets)
16.17. Sandoz (a spin-off of Novartis)
16.18. Sichuan Kelun Pharmaceutical Co., Ltd.
16.19. Terumo Corp.
16.20. Teva Pharmaceutical Industries Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Large Volume Parenteral Market, Years Considered for the Study
FIGURE 2. Global Large Volume Parenteral Market, Research Design
FIGURE 3. Global Large Volume Parenteral Market, Research Framework
FIGURE 4. Global Large Volume Parenteral Market, Data Triangulation
FIGURE 5. Global Large Volume Parenteral Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Large Volume Parenteral Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Large Volume Parenteral Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Large Volume Parenteral Market Size, by Packaging, 2025 vs 2032 (%)
FIGURE 9. Global Large Volume Parenteral Market Size, by Packaging, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Large Volume Parenteral Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Large Volume Parenteral Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Large Volume Parenteral Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Large Volume Parenteral Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Large Volume Parenteral Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Large Volume Parenteral Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Large Volume Parenteral Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Large Volume Parenteral Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Large Volume Parenteral Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Large Volume Parenteral Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Large Volume Parenteral Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Large Volume Parenteral Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Large Volume Parenteral Market Segmentation & Coverage
TABLE 2. Global Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 3. Global Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Colloids Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Colloids Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Colloids Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Albumin Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Albumin Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Albumin Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Dextrans Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Dextrans Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Dextrans Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Gelatins Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Gelatins Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Gelatins Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Hydroxyethyl Starch Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Hydroxyethyl Starch Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Hydroxyethyl Starch Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Crystalloids Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Crystalloids Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Crystalloids Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Balanced Electrolyte Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Balanced Electrolyte Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Balanced Electrolyte Solutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Dextrose Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Dextrose Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Dextrose Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Normal Saline Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Normal Saline Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Normal Saline Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Ringer's Lactate Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Ringer's Lactate Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Ringer's Lactate Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 35. Global Bags Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Bags Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Bags Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Bottles Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Bottles Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Bottles Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Plastic Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Plastic Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Plastic Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Glass Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Glass Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Glass Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 48. Global Ambulatory Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Ambulatory Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Ambulatory Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 61. Global Blood Volume Expansion Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Blood Volume Expansion Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Blood Volume Expansion Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Fluid Replacement Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Fluid Replacement Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Fluid Replacement Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Medication Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Medication Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Medication Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Nutritional Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Nutritional Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Nutritional Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 74. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Large Volume Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Large Volume Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. North America Large Volume Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. North America Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 92. North America Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 93. North America Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 94. North America Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 95. North America Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 96. North America Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. North America Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. North America Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 99. Latin America Large Volume Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Latin America Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 101. Latin America Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 102. Latin America Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 103. Latin America Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 104. Latin America Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 105. Latin America Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. Latin America Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. Latin America Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. Europe Large Volume Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Europe Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 110. Europe Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 111. Europe Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 112. Europe Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 113. Europe Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 114. Europe Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. Europe Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 116. Europe Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. Middle East Large Volume Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Middle East Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 119. Middle East Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 120. Middle East Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 121. Middle East Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 122. Middle East Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 123. Middle East Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. Middle East Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. Middle East Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 126. Africa Large Volume Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Africa Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 128. Africa Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 129. Africa Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 130. Africa Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 131. Africa Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 132. Africa Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Africa Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. Africa Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 135. Global Large Volume Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. ASEAN Large Volume Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. ASEAN Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. ASEAN Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 139. ASEAN Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 140. ASEAN Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 141. ASEAN Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 142. ASEAN Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. ASEAN Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. ASEAN Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 145. GCC Large Volume Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. GCC Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 147. GCC Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 148. GCC Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 149. GCC Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 150. GCC Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 151. GCC Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. GCC Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. GCC Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 154. European Union Large Volume Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. European Union Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 156. European Union Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 157. European Union Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 158. European Union Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 159. European Union Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 160. European Union Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. European Union Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. European Union Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 163. BRICS Large Volume Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. BRICS Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. BRICS Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 166. BRICS Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 167. BRICS Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 168. BRICS Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 169. BRICS Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. BRICS Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. BRICS Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. G7 Large Volume Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. G7 Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 174. G7 Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 175. G7 Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 176. G7 Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 177. G7 Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 178. G7 Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. G7 Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. G7 Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 181. NATO Large Volume Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. NATO Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. NATO Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 184. NATO Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 185. NATO Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 186. NATO Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 187. NATO Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. NATO Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. NATO Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. Global Large Volume Parenteral Market Size, by Country, 2017-2032 (USD Million)
TABLE 191. United States Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 192. United States Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. United States Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 194. United States Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 195. United States Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 196. United States Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 197. United States Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. United States Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. United States Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. Canada Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 201. Canada Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 202. Canada Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 203. Canada Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 204. Canada Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 205. Canada Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 206. Canada Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. Canada Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. Canada Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 209. Mexico Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 210. Mexico Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 211. Mexico Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 212. Mexico Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 213. Mexico Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 214. Mexico Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 215. Mexico Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Mexico Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. Mexico Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 218. Brazil Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 219. Brazil Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 220. Brazil Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 221. Brazil Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 222. Brazil Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 223. Brazil Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 224. Brazil Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. Brazil Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. Brazil Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 227. United Kingdom Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 228. United Kingdom Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 229. United Kingdom Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 230. United Kingdom Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 231. United Kingdom Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 232. United Kingdom Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 233. United Kingdom Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. United Kingdom Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. United Kingdom Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 236. Germany Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 237. Germany Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 238. Germany Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 239. Germany Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 240. Germany Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 241. Germany Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 242. Germany Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Germany Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. Germany Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 245. France Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 246. France Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 247. France Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 248. France Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 249. France Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 250. France Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 251. France Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. France Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. France Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 254. Russia Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 255. Russia Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 256. Russia Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 257. Russia Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 258. Russia Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 259. Russia Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 260. Russia Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. Russia Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. Russia Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 263. Italy Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 264. Italy Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 265. Italy Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 266. Italy Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 267. Italy Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 268. Italy Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 269. Italy Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. Italy Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 271. Italy Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 272. Spain Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 273. Spain Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 274. Spain Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 275. Spain Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 276. Spain Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 277. Spain Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 278. Spain Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. Spain Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. Spain Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 281. China Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 282. China Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 283. China Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 284. China Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 285. China Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 286. China Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 287. China Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 288. China Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. China Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 290. India Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 291. India Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 292. India Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 293. India Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 294. India Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 295. India Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 296. India Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 297. India Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 298. India Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 299. Japan Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 300. Japan Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 301. Japan Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 302. Japan Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 303. Japan Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 304. Japan Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 305. Japan Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. Japan Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 307. Japan Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 308. Australia Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 309. Australia Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 310. Australia Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 311. Australia Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 312. Australia Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 313. Australia Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 314. Australia Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 315. Australia Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 316. Australia Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 317. South Korea Large Volume Parenteral Market Size, 2017-2032 (USD Million)
TABLE 318. South Korea Large Volume Parenteral Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 319. South Korea Large Volume Parenteral Market Size, by Colloids, 2017-2032 (USD Million)
TABLE 320. South Korea Large Volume Parenteral Market Size, by Crystalloids, 2017-2032 (USD Million)
TABLE 321. South Korea Large Volume Parenteral Market Size, by Packaging, 2017-2032 (USD Million)
TABLE 322. South Korea Large Volume Parenteral Market Size, by Bottles, 2017-2032 (USD Million)
TABLE 323. South Korea Large Volume Parenteral Market Size, by End User, 2017-2032 (USD Million)
TABLE 324. South Korea Large Volume Parenteral Market Size, by Application, 2017-2032 (USD Million)
TABLE 325. South Korea Large Volume Parenteral Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 326. Global Large Volume Parenteral Market Share, by Key Player, 2025
TABLE 327. Global Large Volume Parenteral Market, Key Experts

Companies Mentioned

  • Abbott Laboratories Inc.
  • Albert David Ltd.
  • Amanta Healthcare
  • B. Braun Melsungen AG
  • BAG Healthcare GmbH
  • Baxter International Inc.
  • Becton Dickinson & Co. (BD)
  • Beximco Pharmaceutical Ltd.
  • Cipla Limited
  • Cook Pharmica LLC
  • Fresenius Kabi AG
  • Grifols S.A.
  • ICU Medical Inc.
  • JW Life Science
  • Otsuka Pharmaceutical Co. (Otsuka Holdings Co., Ltd.)
  • Pfizer Inc. (including Hospira assets)
  • Sandoz (a spin-off of Novartis)
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Terumo Corp.
  • Teva Pharmaceutical Industries Ltd.